The interaction of APOE genotype by age in amnestic mild cognitive impairment: A voxel-based morphometric study

Journal of Alzheimer's Disease

Volumn 43, Issue 2, 2015, Pages 657-668

  Chen, Jiu ^a   Shu, Hao ^a   Wang, Zan ^a   Liu, Duan ^a   Shi, Yongmei ^a   Zhang, Xiangrong ^a   Zhang, Zhijun ^a  

^a SOUTHEAST UNIVERSITY   (China)

Author keywords

Age; amnestic mild cognitive impairment; apolipoprotein E; episodic memory; voxel based morphometry

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; AGING; ALLELE; ARTICLE; BRAIN REGION; BRAIN SIZE; CALCARINE SULCUS; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; GENOTYPE; GRAY MATTER; HUMAN; IMAGE PROCESSING; INSULA; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; MILD COGNITIVE IMPAIRMENT; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; VOXEL BASED MORPHOMETRY; ANALYSIS OF VARIANCE; BRAIN; GENETICS; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY;

AGE FACTORS; AGED; AGING; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; BRAIN; FEMALE; GENOTYPE; GRAY MATTER; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 84911933619     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141677     Document Type: Article

References (66)

1. Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, Smith GE, Jack CR Jr (2009) Mild cognitive impairment: Ten years later. Arch Neurol 66, 1447-1455.
2. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58, 1985-1992.
3. Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, VanderBilt J, Hughes TF, Loewenstein DA, Unverzagt FW, PetersenRC (2011) Outcomes of mild cognitive impairment by definition:A population study. Arch Neurol 68, 761-767.
4. Brodaty H, Heffernan M, Kochan NA, Draper B, Trollor JN, Reppermund S, Slavin MJ, Sachdev PS (2013) Mild cognitiveimpairment in a community sample: The Sydney memory andageing study. Alzheimers Dement 9, 310-317.
5. Dong Y, Yean Lee W, Hilal S, Saini M, Wong TY, Chen CL, Venketasubramanian N, Ikram MK (2013) Comparisonof the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a populationbased study. Int Psychogeriatr 25, 1831-1838.
6. Stoub TR, deToledo-Morrell L, Stebbins GT, Bennett DA, Shah RC (2006) Hippocampal disconnection contributes tomemory dysfunction in individuals at risk for Alzheimer'sdisease. Proc Natl Acad Sci USA 103, 10041-10045.
7. Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC (2008) Magnetic resonance imagingcharacterization of brain structure and function in mild cognitiveimpairment: A review. J Am Geriatr Soc 56, 920-934.
8. Hämälaïnen A, Grau-Olivares M, Tervo S, Niskanen E, Pennanen C, Huuskonen J, Kivipelto M, Hanninen T, Tapiola M, Vanhanen M, Hallikainen M, Helkala EL, Nissinen A, Vanninen RL, Soininen H (2008) Apolipoprotein E epsilon 4allele is associated with increased atrophy in progressive mildcognitive impairment: A voxel-based morphometric study. Neurodegener Dis 5, 186-189.
9. Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ (2010) Whole genome association study of brainwideimaging phenotypes for identifying quantitative trait lociin MCI and AD: A study of the ADNI cohort. Neuroimage 53, 1051-1063.
10. Spampinato MV, Rumboldt Z, Hosker RJ, Mintzer JE (2011) Apolipoprotein E and gray matter volume loss in patients withmild cognitive impairment and Alzheimer disease. Radiology 258, 843-852.
11. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: Far morethan a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507-537.
12. Mahley RW, Weisgraber KH, HuangY (2006) ApolipoproteinE4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci USA 103, 5644-5651.
13. Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR (2013) Dissecting the gene dose-effects of the APOE-4 and-2 alleles on hippocampal volumes in aging and Alzheimer'sdisease. PLoS One 8, e54483.
14. FarlowMR (1997) Alzheimer's disease: Clinical implicationsof the apolipoprotein E genotype. Neurology 48, S30-S34.
15. Berg L, McKeel DWJr, Miller JP (1998) Clinicopathologicalstudies in cognitively healthy aging and Alzheimer disease:Relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. Arch Neurol 55, 326-335.
16. Mosconi L, Sorbi S, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Herholz K, Pupi A (2004) Age and ApoE genotypeinteraction in Alzheimer's disease: An FDG-PET study. Psychiatry Res 130, 141-151.
17. Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R (2005) Predictive utility of apolipoprotein E genotype for Alzheimerdisease in outpatients with mild cognitive impairment. Arch Neurol 62, 975-980.
18. Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J (2001) Declining brain activity in cognitively normalapolipoprotein E epsilon 4 heterozygotes: A foundation forusing positron emission tomography to efficiently test treatmentsto prevent Alzheimer's disease. Proc Natl Acad Sci USA 98, 3334-3339.
19. Okonkwo OC, Alosco ML, Jerskey BA, Sweet LH, Ott BR, Tremont G (2010) Cerebral atrophy, apolipoprotein E-4, and rate of decline in everyday function among patients withamnestic mild cognitive impairment. Alzheimers Dement 6, 404-411.
20. Bonner-Jackson A, Okonkwo O, Tremont G (2012) Apolipoprotein E-2 and functional decline in amnestic mildcognitive impairment and Alzheimer disease. Am J Geriatr Psychiatry 20, 584-593.
21. Isacson O, Seo H, Lin L, Albeck D, Granholm AC (2002) Alzheimer's disease and Down's syndrome: Roles of AP P, trophic factors and ACh. Trends Neurosci 25, 79-84.
22. Rebeck GW, Kindy M, LaDuMJ (2002) Apolipoprotein E and Alzheimer's disease: The protective effects of ApoE2 and E3. J Alzheimers Dis 4, 145-154.
23. Drzezga A, Grimmer T, Henriksen G, Muhlau M, Perneczky R, Miederer I, Praus C, Sorg C, Wohlschläger A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, Kurz A (2009) Effect of APOE genotype on amyloid plaque loadand gray matter volume in Alzheimer disease. Neurology 72, 1487-1494.
24. Xu Q, Walker D, Bernardo A, Brodbeck J, Balestra ME, Huang Y (2008) Intron-3 retention/splicing controls neuronalexpression of apolipoprotein E in the CNS. J Neurosci 28, 1452-1459.
25. Wilson RS, Bienias JL, Berry-Kravis E, Evans DA, BennettDA (2002) The apolipoprotein E-2 allele and decline inepisodic memory. J Neurol Neurosurg Psychiatry 73, 672-677.
26. Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E (2005) APOE genotype and cognitive declinein a middle-aged cohort. Neurology 64, 268-276.
27. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE (2008) ApoE promotes the proteolytic degradationof Abeta. Neuron 58, 681-693.
28. Chiang GC, Insel PS, Tosun D, Schuff N, Truran-Sacrey D, Raptentsetsang ST, Jack CR Jr, Aisen PS, Petersen RC, Weiner MW (2010) Hippocampal atrophy rates and CSFbiomarkers in elderly APOE2 normal subjects. Neurology 75, 1976-1981.
29. Liu Y, Paajanen T, Westman E, Zhang Y, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, SoininenH (2010) APOEepsilon2 allele is associatedwith larger regional cortical thicknesses and volumes. Dement Geriatr Cogn Disord 30, 229-237.
30. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study ofageing in 465 normal adult human brains. Neuroimage 14, 21-36.
31. Filippini N, Ebmeier KP, MacIntosh BJ, Trachtenberg AJ, Frisoni GB, Wilcock GK, Beckmann CF, Smith SM, Matthews PM, Mackay CE (2011) Differential effects of theAPOE genotype on brain function across the lifespan. Neuroimage54, 602-610.
32. PetersenRC (2004) Mild cognitive impairment as a diagnosticentity. J Intern Med 256, 183-194.
33. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC (2004) Mildcognitive impairment-beyond controversies, towards a consensus:Report of the international working group on mildcognitive impairment. J Intern Med 256, 240-246.
34. Bai F, Liao W, Watson DR, Shi Y, Yuan Y, Cohen AD, Xie C, Wang Y, Yue C, Teng Y, Wu D, Jia J, Zhang Z (2011) Mappingthe altered patterns of cerebellar resting-state functionin longitudinal amnestic mild cognitive impairment patients. J Alzheimers Dis 23, 87-99.
35. Bai F, Xie C, Watson DR, Shi Y, Yuan Y, Wang Y, Yue C, Teng Y, Wu D, Zhang Z (2011) Aberrant hippocampal subregionnetworks associated with the classifications of aMCI subjects:A longitudinal resting-state study. PLoS One 6, e29288.
36. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, Toga AW, Jack CR Jr, Schuff N, Weiner MW, Thompson PM (2009) Automated mapping ofhippocampal atrophy in 1-year repeat MRI data from 490 subjectswith Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 45, S3-S15.
37. Zhang H, Trollor JN, Wen W, Zhu W, Crawford JD, Kochan NA, Slavin MJ, Brodaty H, Reppermund S, Kang K, Mather KA, Sachdev PS (2011) Grey matter atrophy of basal forebrainand hippocampus in mild cognitive impairment. J Neurol Neurosurg Psychiatry 82, 487-493.
38. Fleisher A, Grundman M, Jack CR Jr, Petersen RC, Taylor C, Kim HT, Schiller DH, Bagwell V, Sencakova D, Weiner MF, DeCarli C, DeKosky ST, van Dyck CH, Thal LJ (2005) Sex, apolipoprotein E epsilon 4 status, and hippocampal volumein mild cognitive impairment. Arch Neurol 62, 953-957.
39. Thomann PA, Schlafer C, Seidl U, Santos VD, Essig M, Schroder J (2008) Apolipoprotein E polymorphism and brainmorphology in mild cognitive impairment. Dement GeriatrCogn Disord 26, 300-305.
40. Teipel SJ, Pogarell O, Meindl T, Dietrich O, Sydykova D, Hunklinger U, Georgii B, Mulert C, Reiser MF, Möller HJ, Hampel H (2009) Regional networks underlying interhemisphericconnectivity:AnEEGand DTI study in healthy ageingand amnestic mild cognitive impairment. Hum Brain Map 30, 2098-2119.
41. Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, Julin P (2007) Imaging markers of mild cognitiveimpairment: Multivariate analysis of CBF SPECT. NeurobiolAging 28, 1062-1069.
42. Petrella JR, Krishnan S, Slavin MJ, Tran TT, Murty L, Doraiswamy PM (2006) Mild cognitive impairment: Evaluationwith 4-T functional MR imaging. Radiology 240, 177-186.
43. Schmahmann JD, Weilburg J, Sherman JC (2007) The neuropsychiatryof the cerebellum-insights from the clinic. Cerebellum 6, 254-267.
44. Stoodley CJ, Schmahmann JD (2009) Functional topographyin the human cerebellum: A meta-analysis of neuroimagingstudies. Neuroimage 44, 489-501.
45. Baloyannis SJ, Manolidis SL, Manolidis LS (2000) Synapticalterations in the vestibulocerebellar system in Alzheimer'sdisease-a Golgi and electron microscope study. Acta Otolaryngol 120, 247-250.
46. Sjöbeck M, Englund E (2001) Alzheimer's disease and thecerebellum: A morphologic study on neuronal and glialchanges. Dement Geriatr Cogn Disord 12, 211-218.
47. Ishii K, Sasaki M, Kitagaki H, Yamaji S, Sakamoto S, Matsuda K, Mori E (1997) Reduction of cerebellar glucose metabolismin advanced Alzheimer's disease. J Nucl Med 38, 925-928.
48. Bas O, Acer N, Mas N, Karabekir HS, Kusbeci OY, SahinB (2009) Stereological evaluation of the volume and volumefraction of intracranial structures in magnetic resonanceimages of patients with Alzheimer's disease. Ann Anat 191, 186-195.
49. Davatzikos C, Bhatt P, Shaw LM, Batmanghelich KN, TrojanowskiJQ (2011) Prediction of MCI to AD conversion, via MR I, CSF biomarkers, and pattern classification. Neurobiol Aging 32, e2319-e2327.
50. Goñi J, Cervantes S, Arrondo G, Lamet I, Pastor P, PastorMA (2013) Selective brain gray matter atrophy associatedwith APOE-4 and MAPT H1 in subjects with mild cognitiveimpairment. J Alzheimers Dis 33, 1009-1019.
51. Nho K, Risacher SL, Crane PK, DeCarli C, Glymour MM, Habeck C, Kim S, Lee GJ, Mormino E, Mukherjee S, Shen L, West JD, Saykin AJ (2012) Voxel and surface-based topographyof memory and executive deficits in mild cognitiveimpairment and Alzheimer's disease. Brain Imaging Behav 6, 551-567.
52. Scheff SW, Price DA, Schmitt FA, Scheff MA, Mufson EJ (2011) Synaptic loss in the inferior temporal gyrus in mildcognitive impairment and Alzheimer's disease. J Alzheimers Dis 24, 547-557.
53. Spulber G, Niskanen E, Macdonald S, Kivipelto M, Padilla DF, Julkunen V, Hallikainen M, Vanninen R, Wahlund LO, Soininen H (2012) Evolution of global and local grey matteratrophy on serial MRI scans during the progression from MCIto AD. Curr Alzheimer Res 9, 516-524.
54. Borenstein AR, Mortimer JA, Ding Ding, Schellenberg GD, DeCarli C, Qianhua Zhao, Copenhaver C, Qihao Guo, Shugang Chu, Galasko D, Salmon DP, Qi Dai, Yougui Wu, Petersen R, Zhen Hong (2010) Effects of apolipoprotein E-4and-2 in amnestic mild cognitive impairment and dementiain Shanghai: SCOBHI-P. Am J Alzheimers Dis Other Demen 25, 233-238.
55. Lovati C, Galimberti D, Albani D, Bertora P, Venturelli E, Cislaghi G, Guidi I, Fenoglio C, Cortini F, Clerici F, Finazzi D, Forloni G, Scarpini E, Mariani C (2010) APOE-2 and-4influence the susceptibility for Alzheimer's disease but notother dementias. Int J Mol Epidemiol Genet 1, 193-200.
56. Berlau DJ, Corrada MM, Head E, Kawas CH (2009) APOE-2 is associated with intact cognition but increased Alzheimerpathology in the oldest old. Neurology 72, 829-834.
57. Teter B, Raber J, Nathan B, Crutcher KA (2002) The presenceof apoE4, not the absence of apoE3, contributes to ADpathology. J Alzheimers Dis 4, 155-163.
58. Crivello F, Lemaitre H, Dufouil C, Grassiot B, Delcroix N, Tzourio-Mazoyer N, Tzourio C, Mazoyer B (2010) Effects ofApoE-epsilon4 allele load and age on the rates of grey matterand hippocampal volumes loss in a longitudinal cohort of1186 healthy elderly persons. Neuroimage 53, 1064-1069.
59. Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW (1999) Expression of humanapolipoprotein E3 or E4 in the brains of Apoe-/-mice:Isoform-specific effects on neurodegeneration. J Neurosci 19, 4867-4880.
60. Albert SM, Gurland B, Maestre G, Jacobs DM, Stern Y, Mayeux R (1995) APOE genotype influences functional statusamong elderly without dementia. Am J Med Genet 60, 583-587.
61. Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD (1997) Apolipoprotein E-2 and Alzheimer'sdisease: Genotype influences pathologic phenotype. Neurology 48, 515-519.
62. Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J (2004) Impact of APOE genotype onneuropathologic and neurochemical markers of Alzheimerdisease. Neurology 62, 1977-1983.
63. Head E, Corrada MM, Kahle-Wrobleski K, Kim RC, Sarsoza F, Goodus M, Kawas CH (2009) Synaptic proteins, neuropathologyand cognitive status in the oldest-old. Neurobiol Aging 30, 1125-1134.
64. Ignatov I, Belden C, Jacobson S, Connor D, Sabbagh MN (2009) Possible Alzheimer's disease in an apolipoprotein E2homozygote. J Alzheimers Dis 16, 35-38.
65. Lung FW, Yen YC, Chou LJ, Hong CJ, Wu CK (2005) Theallele interaction between apolipoprotein-2 and-4 in TaiwaneseAlzheimer's disease patients. Acta Psychiatr Scand 111, 38-43.
66. Xie C, Bai F, Yu H, Shi Y, Yuan Y, Chen G, Zhang Z, LiSJ (2012) Abnormal insula functional network is associated with episodic memory decline in amnestic mild cognitive impairment. Neuroimage 63, 320-327.